Journal article

Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium

Mia M Gaudet, Roger L Milne, Angela Cox, Nicola J Camp, Ellen L Goode, Manjeet K Humphreys, Alison M Dunning, Jonathan Morrison, Graham G Giles, Gianluca Severi, Laura Baglietto, Dallas R English, Fergus J Couch, Janet E Olson, Xianshu Wang, Jenny Chang-Claude, Dieter Flesch-Janys, Sascha Abbas, Ramona Salazar, Arto Mannermaa Show all

Cancer Epidemiology, Biomarkers & Prevention | AMER ASSOC CANCER RESEARCH | Published : 2009

Grants

Awarded by Australian National Health and Medical Research Council


Awarded by National Institutes of Health


Awarded by U.S. medical research and materiel command breast cancer IDEA award


Awarded by Deutsche Krebshilfe e.V.


Awarded by The Academy of Finland


Awarded by Deutsche Krebshilfe


Awarded by Federal Ministry of Education and Research (BMBF) Germany


Awarded by Dutch Cancer Society


Awarded by National Health and Medical Research Council (NHMRC)


Awarded by National Cancer Institute (USA)


Awarded by National Cancer Institute (NCI)


Awarded by NCT


Awarded by National Research and Development Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea


Awarded by Lon v smith Foundation (LVSF)


Awarded by Susan G. Komen Foundation


Awarded by Utah Cancer Registry


Awarded by U.S. Army Medical Research and Materiel Command


Awarded by Cancer Research UK


Funding Acknowledgements

The authors are grateful to Study Coordinators, Laboratory Specialst Kim Nguyen, and Computer Specialist Jathine Wong. We wish to thank Heather Thorne, Eveline Niedermayr, all the kConFab research nurses and staff, the heads and staff of the Family Cancer Clinics, and the Clinical Follow Up Study (funded by NHMRC grants 145684, 288704 and 454508) for their contributions to this resource, and the many families who contribute to kConFab. kConFab is supported by grants from the National Breast Cancer Foundation, the National Health and Medical Research Council (NHMRC) and by the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. ACS/AOCS: The AOCS Management Group (D Bowtell, G Chenevix-Trench, A deFazio, D Gertig, A Green, P Webb) gratefully acknowledges the contribution of all the clinical and scientific collaborators (see http://www.aocstudy.org/), AOCS and the ACS Management Group (A Green, P Parsons, N Hayward, P Webb, D Whiteman) thank all of the project staff, collaborating institutions and Study participants. Financial support was provided by: U.S. Army Medical Research and Materiel Command under DAMD17-01-1-0729, the Cancer Council Tasmania and Cancer Foundation of Western Australia (AOCS study); The National Health and Medical Research Council of Australia (199600) (ACS study). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centres in the CFRs, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government or the CFRs Centers. The genotyping and analysis were supported by grants from the National Health and Medical Research Council (NHMRC). ABS was funded by an NHMRC Career Development Award, and GC-T and JLH are NHMRC Senior Principal Research Fellows.